Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 1

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Hyper eosinophilic diseases – diagnosis and therapeutic approach – practical position of the Polish working group

100%
Kuna P., Jassem E., Wiatr E., Bazan-Socha S., Kupryś-Lipińska I.
Polish Journal of Otolaryngology
|
2024
|
vol. 78
|
issue 6
48-60
EN
Hypereosinophilic diseases represent a heterogeneous group that poses a significant medical challenge. An increased number of eosinophils in the blood can be a dominant symptom of hematologic diseases, such as myeloid hematopoietic cancers or lymphomas. However, it is more commonly associated with other health conditions, such as allergies, infections, and systemic inflammatory diseases. Distinguishing between eosinophilic vasculitis with polyangiopathy (EGPA) and idiopathic hypereosinophilic syndrome (I-HES) can be difficult in clinical practice. In this report, we provide practical guidelines for clinicians that may aid in the diagnosis and treatment of these diseases. Additionally, we discuss the role of biologic IL-5 inhibitors in their therapy, as mepolizumab is approved for the treatment of EGPA and I-HES. We believe that the proposed guidelines will be helpful for clinicians, especially those who are not familiar with hypereosinophilic diseases.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.